Lexaria Bioscience Corp.
LEXX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348362
No open-market purchases or sales by Lexaria Bioscience Corp. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $920.0K in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Lexaria Bioscience Corp. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 20 | 25 | +5 |
| Shares | 1.20M | 888.8K | −307.2K (−25.7%) |
| Value | $1.49M | $3.23M | +$1.73M (+115.8%) |
New holders (10)
Institutions that held Lexaria Bioscience Corp. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Raymond James Financial Services Advisors, Inc. | 39,550 | $143.6K | 0.00% |
| State Street Corp | 39,301 | $142.7K | 0.00% |
| Welch Group, LLC | 24,000 | $87.1K | 0.00% |
| Morgan Stanley | 23,354 | $84.8K | 0.00% |
| Northern Trust Corp | 18,389 | $66.8K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 10,323 | $37.5K | 0.00% |
| XTX Topco Ltd | 10,276 | $37.3K | 0.01% |
| Oakworth Capital, Inc. | 5,000 | $18.1K | 0.00% |
| BlackRock Inc. | 1,508 | $5.47K | 0.00% |
| Bank of America Corp | 237 | $860 | 0.00% |
Sold out (5)
Institutions that held Lexaria Bioscience Corp. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Cowen and Company, LLC | 256,327 | $320.4K |
| Connective Capital Management, LLC | 60,000 | $75.0K |
| UBS Group AG | 4,532 | $5.67K |
| JPMorgan Chase & Co | 1,019 | $1.27K |
| Sound Income Strategies, LLC | 22 | $28 |